Literature DB >> 17646418

Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.

Anouk E Muller1, Joost DeJongh, Ymka Bult, Wil H F Goessens, Johan W Mouton, Meindert Danhof, John N van den Anker.   

Abstract

The pharmacokinetics of penicillin G were studied in 20 preterm neonates with a gestational age of less than 32 weeks on day 3 of life by using a population approach performed with the nonlinear mixed effects modeling program NONMEM. The derived population estimates and the correlation matrix of these estimates were used to perform Monte Carlo simulations and obtain the probability of target attainment (PTA). The pharmacokinetics of penicillin G were best described by a two-compartment pharmacokinetic model. The population estimates of the central volume of distribution, the peripheral volume of distribution, the intercompartmental clearance, and the total body clearance were 0.359 +/- 0.06 liter, 0.152 +/- 0.03 liter, 0.774 +/- 0.28 liter/h, and 0.103 +/- 0.01 liter/h (mean +/- standard error), respectively. The terminal half-life was 3.9 h. Clearance increased significantly with increasing birth weight. Assuming the percentage of time that the concentration of unbound drug remained above the MIC of 50% for preterm neonates, the susceptibility breakpoint based on a 100% PTA was < or =4 mg/liter, simulating the current dosing regimen of 50,000 U/kg every 12 h. This regimen is therefore adequate for the treatment of common infections in neonates on the third day of life.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17646418      PMCID: PMC2043294          DOI: 10.1128/AAC.00318-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unit.

Authors:  Johan W Mouton; Nieko Punt; Alexander A Vinks
Journal:  Clin Ther       Date:  2005-06       Impact factor: 3.393

Review 2.  New dosing strategies for antibacterial agents in the neonate.

Authors:  Matthijs de Hoog; Johan W Mouton; John N van den Anker
Journal:  Semin Fetal Neonatal Med       Date:  2004-12-01       Impact factor: 3.926

Review 3.  Population clinical pharmacology of children: modelling covariate effects.

Authors:  Brian J Anderson; Karel Allegaert; Nicholas H G Holford
Journal:  Eur J Pediatr       Date:  2006-06-29       Impact factor: 3.183

Review 4.  Pharmacological research in pediatrics: From neonates to adolescents.

Authors:  Natella Y Rakhmanina; John N van den Anker
Journal:  Adv Drug Deliv Rev       Date:  2006-03-13       Impact factor: 15.470

5.  Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003.

Authors:  Barbara J Stoll; Nellie I Hansen; Rosemary D Higgins; Avroy A Fanaroff; Shahnaz Duara; Ronald Goldberg; Abbot Laptook; Michelle Walsh; William Oh; Ellen Hale
Journal:  Pediatr Infect Dis J       Date:  2005-07       Impact factor: 2.129

Review 6.  Neonatal infection and long-term neurodevelopmental outcome in the preterm infant.

Authors:  Ira Adams-Chapman; Barbara J Stoll
Journal:  Curr Opin Infect Dis       Date:  2006-06       Impact factor: 4.915

Review 7.  Infection in late preterm infants.

Authors:  Daniel K Benjamin; Barbara J Stoll
Journal:  Clin Perinatol       Date:  2006-12       Impact factor: 3.430

8.  Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of abacavir and amprenavir.

Authors:  G L Drusano; D Z D'Argenio; S L Preston; C Barone; W Symonds; S LaFon; M Rogers; W Prince; A Bye; J A Bilello
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

9.  Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks.

Authors:  J J Huisman-de Boer; J N van den Anker; M Vogel; W H Goessens; R C Schoemaker; R de Groot
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

Review 10.  Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins.

Authors:  W A Craig
Journal:  Diagn Microbiol Infect Dis       Date:  1995 May-Jun       Impact factor: 2.803

View more
  14 in total

Review 1.  Clinical pharmacokinetics of penicillins in the neonate: a review of the literature.

Authors:  G M Pacifici; J Labatia; H Mulla; I Choonara
Journal:  Eur J Clin Pharmacol       Date:  2008-09-23       Impact factor: 2.953

2.  Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.

Authors:  Elisabet I Nielsen; Otto Cars; Lena E Friberg
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

Review 3.  Drugs for the Prevention and Treatment of Sepsis in the Newborn.

Authors:  Sagori Mukhopadhyay; Kelly C Wade; Karen M Puopolo
Journal:  Clin Perinatol       Date:  2019-03-30       Impact factor: 3.430

4.  Pediatric anthrax clinical management.

Authors:  John S Bradley; Georgina Peacock; Steven E Krug; William A Bower; Amanda C Cohn; Dana Meaney-Delman; Andrew T Pavia
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

5.  Evaluation of a System-Specific Function To Describe the Pharmacokinetics of Benzylpenicillin in Term Neonates Undergoing Moderate Hypothermia.

Authors:  Yuma A Bijleveld; Timo R de Haan; Johanna H van der Lee; Floris Groenendaal; Peter H Dijk; Arno van Heijst; Rogier C J de Jonge; Koen P Dijkman; Henrica L M van Straaten; Monique Rijken; Inge A Zonnenberg; Filip Cools; Alexandra Zecic; Debbie H G M Nuytemans; Anton H van Kaam; Ron A A Mathôt
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 6.  Population pharmacokinetic analysis during the first 2 years of life: an overview.

Authors:  Amélie Marsot; Audrey Boulamery; Bernard Bruguerolle; Nicolas Simon
Journal:  Clin Pharmacokinet       Date:  2012-12       Impact factor: 6.447

7.  Pharmacokinetics of Penicillin G in Preterm and Term Neonates.

Authors:  Helgi Padari; Tuuli Metsvaht; Eva Germovsek; Charlotte I Barker; Karin Kipper; Koit Herodes; Joseph F Standing; Kersti Oselin; Tõnis Tasa; Hiie Soeorg; Irja Lutsar
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

8.  High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination.

Authors:  Tuuli Metsvaht; Georgi Nellis; Heili Varendi; Anthony J Nunn; Susan Graham; Andre Rieutord; Thomas Storme; James McElnay; Hussain Mulla; Mark A Turner; Irja Lutsar
Journal:  BMC Pediatr       Date:  2015-04-16       Impact factor: 2.125

Review 9.  Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology.

Authors:  Charlotte I S Barker; Eva Germovsek; Rollo L Hoare; Jodi M Lestner; Joanna Lewis; Joseph F Standing
Journal:  Adv Drug Deliv Rev       Date:  2014-01-17       Impact factor: 15.470

10.  Dosing Recommendations for Pediatric Patients With Renal Impairment.

Authors:  Amer Al-Khouja; Kyunghun Park; Daijha J C Anderson; Caitlyn Young; Jian Wang; Shiew Mei Huang; Mona Khurana; Gilbert J Burckart
Journal:  J Clin Pharmacol       Date:  2020-06-15       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.